rs373185098
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 2P and 8B. PM5BP4_StrongBS2
The NM_001370466.1(NOD2):c.1679G>A(p.Arg560His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R560C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001370466.1 missense
Scores
Clinical Significance
Conservation
Publications
- Blau syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, G2P, Illumina, Labcorp Genetics (formerly Invitae)
- inflammatory bowel disease 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NOD2 | NM_001370466.1 | c.1679G>A | p.Arg560His | missense_variant | Exon 4 of 12 | ENST00000647318.2 | NP_001357395.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NOD2 | ENST00000647318.2 | c.1679G>A | p.Arg560His | missense_variant | Exon 4 of 12 | NM_001370466.1 | ENSP00000495993.1 | |||
| NOD2 | ENST00000300589.6 | c.1760G>A | p.Arg587His | missense_variant | Exon 4 of 12 | 1 | ENSP00000300589.2 | |||
| NOD2 | ENST00000641284.2 | n.1679G>A | non_coding_transcript_exon_variant | Exon 4 of 6 | ENSP00000493088.1 | |||||
| NOD2 | ENST00000646677.2 | n.1679G>A | non_coding_transcript_exon_variant | Exon 4 of 13 | ENSP00000496533.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152232Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000200 AC: 5AN: 250346 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461128Hom.: 0 Cov.: 34 AF XY: 0.0000179 AC XY: 13AN XY: 726876 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74372 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Regional enteritis;C5201146:Blau syndrome Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 587 of the NOD2 protein (p.Arg587His). This variant is present in population databases (rs373185098, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with NOD2-related conditions. ClinVar contains an entry for this variant (Variation ID: 570145). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt NOD2 protein function with a negative predictive value of 95%. This variant disrupts the p.Arg587 amino acid residue in NOD2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17968944, 30693132, 32647028). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at